As an instance, in the study of Gagini et al., (2017) on the mRNA level, a significant difference was observed between irisin in the liver of the patients with hepatocellular carcinoma (HCC) and that of the controls; however, irisin concentration in plasma was not significantly different between cancer and control groups. The gene discussed is FNDC5; the disease is cancer.